OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.
Visit our booth B36 at DIA. If you are interested in an optimal safety (PASS) study, OXON’s expert team, supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene and Tropical Medicine can help you face your PASS and PAES challenges.
OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.
OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.
OXON is planning a series of webinars in 2019 with leading EU and Asian pharmacoepidemiologists and involving our close collaboration with Professor Stuart Pocock
We were delighted to win first prize in the BRACE poster award for a novel hybrid design for a 6-country study approved by PRAC at ISPE International Conference in Prague.
OXON will be supporting ISPE International Conference on Pharmacoepidemiology and Therapeutic Risk Management (34th ICPE 2018) that will be held August 22-26, 2018, at the Prague Congress Centre.
